Cytokine elevation in sudden death with respiratory syncytial virus: A case report of 2 children

Pediatrics

Volumn 138, Issue 6, 2016, Pages

  Kakimoto, Yu ^a   Seto, Yoshihisa ^a   Ochiai, Eriko ^a   Satoh, Fumiko ^a   Osawa, Motoki ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; EPINEPHRINE; INTERLEUKIN 6; INTERLEUKIN 8; PARACETAMOL; CYTOKINE;

AIRWAY OBSTRUCTION; ARTICLE; AUTOPSY; BRAIN EDEMA; BRONCHIOLITIS; BRONCHUS EPITHELIUM; CARDIOPULMONARY ARREST; CASE REPORT; CEREBROSPINAL FLUID LEVEL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CORRELATIONAL STUDY; COUGHING; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; MACROPHAGE; MALE; NONHUMAN; PATIENT RISK; PNEUMONIA; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESUSCITATION; SUDDEN DEATH; SYMPTOM; THORAX RADIOGRAPHY; VIRUS IDENTIFICATION; BLOOD; CAUSE OF DEATH; ETIOLOGY; INFANT; MORTALITY; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY;

CAUSE OF DEATH; CYTOKINES; DEATH, SUDDEN; FEMALE; HUMANS; INFANT; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85008315340     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-1293     Document Type: Article

References (31)

1. Piedimonte G. RSV infections: State of the art. Cleve Clin J Med. 2015;82(11 suppl 1):S13-S18
2. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitisassociated hospitalizations among US children, 1980-1996. JAMA. 1999;282(15):1440-1446
3. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-186
4. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588-598
5. Saviæ N, Jankoviæ B, Miniæ P, et al. Clinical characteristics of respiratory syncytial virus infection in neonates and young infants. Vojnosanit Pregl. 2011;68(3):220-224
6. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr. 2000;137(6):865-870
7. American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134(2):415-420
8. Pollack P, Groothuis JR. Development and use of palivizumab (Synagis): a passive immunoprophylactic agent for RSV. J Infect Chemother. 2002;8(3):201-206
9. Brooks AM, McBride JT, McConnochie KM, Aviram M, Long C, Hall CB. Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics. 1999;104(3 Pt 1):463-467
10. Hall CB, Weinberg GA, Blumkin AK, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132(2). Available at: www.pediatrics.org/cgi/content/full/132/2/e341
11. Mori M, Kawashima H, Nakamura H, et al; Surveillance Committee for Severe RSV Infection. Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan. J Infect Chemother. 2011;17(2):254-263
12. Hosoya M, Kawasaki Y, Katayose M, et al. Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure. Arch Dis Child. 2006;91(6):469-472
13. Morichi S, Morishita N, Ishida Y, et al. Examination of neurological prognostic markers in patients with respiratory syncytial virus-associated encephalopathy [published online ahead of print February 1, 2016]. Int J Neurosci. 2016. doi: 10. 3109/00207454. 2016. 1138951
14. Brown PM, Schneeberger DL, Piedimonte G. Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatr Respir Rev. 2015;16(4):232-240
15. Ichiyama T, Morishima T, Isumi H, Matsufuji H, Matsubara T, Furukawa S. Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine. 2004;27(1):31-37
16. Seki T, Joh K, Oh-ishi T. Augmented production of interleukin-8 in cerebrospinal fluid in bacterial meningitis. Immunology. 1993;80(2):333-335
17. Mãrginean CO, Man L, Pitea AM, Man A, Mãrginean CL, Cotoi OS. The assessment between IL-6 and IL-8 and anthropometric status in malnourished children. Rom J Morphol Embryol. 2013;54(4):935-938
18. Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand Suppl. 2007;186:45-56
19. Arnold R, Humbert B, Werchau H, Gallati H, König W. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology. 1994;82(1):126-133
20. Arnold R, König B, Galatti H, Werchau H, König W. Cytokine (IL-8, IL-6, TNFalpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Immunology. 1995;85(3):364-372
21. Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol. 1993;265(5 Pt 1):L472-L478
22. Bao Z, Ye Q, Gong W, Xiang Y, Wan H. Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. Int Immunopharmacol. 2010;10(2):259-263
23. Goldman JL, Sammani S, Kempf C, et al. Pleiotropic effects of interleukin-6 in a "two-hit" murine model of acute respiratory distress syndrome. Pulm Circ. 2014;4(2):280-288
24. Otake Y, Yamagata T, Morimoto Y, et al. Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev. 2007;29(2):117-120
25. Kawashima H, Kashiwagi Y, Ioi H, et al. Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations. J Infect Chemother. 2012;18(6):827-831
26. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992;131(2):710-714
27. Yu H, Huang X, Ma Y, et al. Interleukin-8 regulates endothelial permeability by down-regulation of tight junction but not dependent on integrins induced focal adhesions. Int J Biol Sci. 2013;9(9):966-979
28. Cranswick N, Coghlan D. Paracetamol efficacy and safety in children: the first 40 years. Am J Ther. 2000;7(2):135-141
29. de Martino M, Chiarugi A. Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management. Pain Ther. 2015;4(2):149-168
30. Mahadevan SB, McKiernan PJ, Davies P, Kelly DA. Paracetamol induced hepatotoxicity. Arch Dis Child. 2006;91(7):598-603
31. Rajanayagam J, Bishop JR, Lewindon PJ, Evans HM. Paracetamol-associated acute liver failure in Australian and New Zealand children: high rate of medication errors. Arch Dis Child. 2015;100(1):77-80